Whereas in CRC, despite little ALKBH5 expression, studies have found that external introduction of high levels of ALKBH5 can effectively suppress colorectal cancer progression by inhibiting glycolysis [101]. The gene discussed is ALKBH5; the disease is colorectal carcinoma.